Complement C3a, CpG Oligos, and DNA/C3a Complex Stimulate IFN-a Production in a Receptor for Advanced Glycation End Product-Dependent Manner

• Published in: The Journal of immunology (1950) Vol. 185; no. 7; pp. 4213 - 4222
• Main Authors: Ruan, Benfang Helen, Li, Xin, Winkler, Aaron R, Cunningham, Kristina M, Kuai, Jun, Greco, Rita M, Nocka, Karl H, Fitz, Lori J, Wright, Jill F, Pittman, Debra D, Tan, Xiang-Yang, Paulsen, Janet E, Lin, Lih Ling, Winkler, David G
• Format: Journal Article
• Language: English
• Published: 01-10-2010
• ISSN: 0022-1767

The receptor for advanced glycation end products (RAGE) is a multiligand transmembrane receptor implicated in a number of diseases including autoimmune diseases. To further understand the pathogenic mechanism of RAGE in these diseases, we searched for additional ligands. We discovered that C3a bound to RAGE with an EC50 of 1.9 nM in an ELISA, and the binding was increased both in magnitude (by >2-fold) and in affinity (EC50 70 pM) in the presence of human stimulatory unmethylated cytosine-guanine-rich DNA A (hCpGAs). Surface plasmon resonance and fluorescence anisotropy analyses demonstrated that hCpGAs could bind directly to RAGE and C3a and form a ternary complex. In human PBMCs, C3a increased IFN-a production in response to low levels of hCpGAs, and this synergy was blocked by soluble RAGE or by an Ab directed against RAGE. IFN-a production was reduced in response to mouse CpGAs and C3a in RAGE-/- mouse bone marrow cells compared wild-type mice. Taken together, these data demonstrate that RAGE is a receptor for C3a and CpGA. Through direct interaction, C3a and CpGA synergize to increase IFN-a production in a RAGE-dependent manner and stimulate an innate immune response. These findings indicate a potential role of RAGE in autoimmune diseases that show accumulation of immunostimulatory DNA and C3a.